107 related articles for article (PubMed ID: 9825654)
1. [Evaluation of the inhaled glucocorticosteroid effects on non specific bronchial reactivity with particular reference to the late inflammatory phase in atopic asthma patients. II. The effect of regular administration of budesonide R on specific and non-specific bronchial reactivity].
Siergiejko Z; Chyrek-Borowska S; Rogalewska A; Zietkowski Z
Pol Merkur Lekarski; 1998 May; 4(23):250-3. PubMed ID: 9825654
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of the enhaled glucocorticosteroid effect on non-specific and specific bronchial reactivity with particular reference to the late inflammatory phase in atopic asthma patients. I. The effect of a single dose of budesonide R on specific and non-specific bronchial reactivity].
Chyrek-Borowska S; Siergiejko Z; Rogalewska A; Zietkowski Z
Pol Merkur Lekarski; 1998 May; 4(23):247-9. PubMed ID: 9825653
[TBL] [Abstract][Full Text] [Related]
3. [The effect of salmeterol on specific and non-specific bronchial response in allergic asthma patients].
Siergiejko Z
Pneumonol Alergol Pol; 1998; 66(9-10):440-9. PubMed ID: 10354693
[TBL] [Abstract][Full Text] [Related]
4. [Modification of nonspecific bronchial hyperreactivity to cold air hyperventilation and carbachol by nedocromil and budesonide].
Claussen M; Sill V
Pneumologie; 1993 Mar; 47(3):209-14. PubMed ID: 8387191
[TBL] [Abstract][Full Text] [Related]
5. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM
Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153
[TBL] [Abstract][Full Text] [Related]
6. Eosinophil markers in blood, serum, and urine for monitoring the clinical course in childhood asthma: impact of budesonide treatment and withdrawal.
Lönnkvist K; Hellman C; Lundahl J; Halldén G; Hedlin G
J Allergy Clin Immunol; 2001 May; 107(5):812-7. PubMed ID: 11344347
[TBL] [Abstract][Full Text] [Related]
7. Effect of regular terbutaline and budesonide on bronchial reactivity to allergen challenge.
Wong CS; Wahedna I; Pavord ID; Tattersfield AE
Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1268-73. PubMed ID: 7952551
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mast cell tryptase by inhaled APC 366 attenuates allergen-induced late-phase airway obstruction in asthma.
Krishna MT; Chauhan A; Little L; Sampson K; Hawksworth R; Mant T; Djukanovic R; Lee T; Holgate S
J Allergy Clin Immunol; 2001 Jun; 107(6):1039-45. PubMed ID: 11398082
[TBL] [Abstract][Full Text] [Related]
9. Effect of IVL745, a VLA-4 antagonist, on allergen-induced bronchoconstriction in patients with asthma.
Norris V; Choong L; Tran D; Corden Z; Boyce M; Arshad H; Holgate S; O'Connor B; Millet S; Miller B; Rohatagi S; Kirkesseli S
J Allergy Clin Immunol; 2005 Oct; 116(4):761-7. PubMed ID: 16210048
[TBL] [Abstract][Full Text] [Related]
10. Protection by budesonide and fluticasone on allergen-induced airway responses after discontinuation of therapy.
Subbarao P; Dorman SC; Rerecich T; Watson RM; Gauvreau GM; O'Byrne PM
J Allergy Clin Immunol; 2005 Apr; 115(4):745-50. PubMed ID: 15805993
[TBL] [Abstract][Full Text] [Related]
11. [Usefulness of allergen extract Aquagen SQ-Dpt for administering bronchial provocation tests].
Siergiejko Z; Zietkowski Z; Chyrek-Borowska S
Pneumonol Alergol Pol; 1996; 64(11-12):750-7. PubMed ID: 9162319
[TBL] [Abstract][Full Text] [Related]
12. Comparison of high and low dose of the inhaled steroid, budesonide, as an initial treatment in newly detected asthma.
Tukiainen H; Taivainen A; Majander R; Poussa T; Svahn T; Puolijoki H; Terho EO
Respir Med; 2000 Jul; 94(7):678-83. PubMed ID: 10926339
[TBL] [Abstract][Full Text] [Related]
13. [The effect of inhaled heparin on post-leukotriene bronchoconstriction in children with bronchial asthma].
Stelmach I; Jerzyńska J; Bobrowska M; Brzozowska A; Majak P; Kuna P
Pol Merkur Lekarski; 2002 Feb; 12(68):95-8. PubMed ID: 11995261
[TBL] [Abstract][Full Text] [Related]
14. [The effect of local specific bronchial immunotherapy (LIT) on specific and non-specific bronchial hyperreactivity in patients with bronchial asthma sensitive to housedust mites].
Zietkowski Z; Rogalewska AM; Bodzenta-ŁLukaszyk A
Pol Merkur Lekarski; 2000 Oct; 9(52):645-7. PubMed ID: 11144048
[TBL] [Abstract][Full Text] [Related]
15. [Effect of ketotifen, nedocromil sodium and budesonide on non-specific bronchial hyperreactivity to histamine in patients with asthma].
Siergiejko Z; Rutkowski R; Rogalewska A; Kazberuk M
Pneumonol Alergol Pol; 1992; 60(11-12):37-42. PubMed ID: 1338947
[TBL] [Abstract][Full Text] [Related]
16. Exhaled NO and eosinophil markers in blood, nasal lavage and sputum in children with asthma after withdrawal of budesonide.
Lönnkvist K; Anderson M; Hedlin G; Svartengren M
Pediatr Allergy Immunol; 2004 Aug; 15(4):351-8. PubMed ID: 15305945
[TBL] [Abstract][Full Text] [Related]
17. Discrepant nasal and bronchial nitric oxide kinetics during early and late phase allergic reactions.
Korn S; Beier J; Heilmann C; Kornmann O; Buhl R; Michael Beeh K
Respir Med; 2005 Dec; 99(12):1595-9. PubMed ID: 16291080
[TBL] [Abstract][Full Text] [Related]
18. [The effect of the Russian inhalant glucocorticosteroid budesonide on bronchial inflammation and hyperreactivity during the long-term treatment of bronchial asthma patients].
Sutochnikova OA; Samsonova MV; Cherniak AV; Cherniaev AL; Sokolov AS; Chuchalin AG
Ter Arkh; 1996; 68(3):48-50. PubMed ID: 8744104
[TBL] [Abstract][Full Text] [Related]
19. Budesonide/formoterol decreases expression of vascular endothelial growth factor (VEGF) and VEGF receptor 1 within airway remodelling in asthma.
Wang K; Liu CT; Wu YH; Feng YL; Bai HL
Adv Ther; 2008 Apr; 25(4):342-54. PubMed ID: 18421428
[TBL] [Abstract][Full Text] [Related]
20. [The long term effect of small dose budesonide turbuhaler on mild bronchial asthma].
Weng JL; Zheng YS; Ma QF
Zhonghua Jie He He Hu Xi Za Zhi; 2005 Feb; 28(2):88-92. PubMed ID: 15854388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
